rs782192927
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_000116.5(TAFAZZIN):c.584-7delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,210,172 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 19 hemizygotes in GnomAD. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000116.5 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAFAZZIN | NM_000116.5 | c.584-7delT | splice_region_variant, intron_variant | ENST00000601016.6 | NP_000107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAFAZZIN | ENST00000601016.6 | c.584-7delT | splice_region_variant, intron_variant | 1 | NM_000116.5 | ENSP00000469981.1 |
Frequencies
GnomAD3 genomes AF: 0.000142 AC: 16AN: 112340Hom.: 0 Cov.: 23 AF XY: 0.000145 AC XY: 5AN XY: 34510
GnomAD3 exomes AF: 0.0000381 AC: 7AN: 183500Hom.: 0 AF XY: 0.0000736 AC XY: 5AN XY: 67938
GnomAD4 exome AF: 0.0000210 AC: 23AN: 1097832Hom.: 0 Cov.: 31 AF XY: 0.0000385 AC XY: 14AN XY: 363208
GnomAD4 genome AF: 0.000142 AC: 16AN: 112340Hom.: 0 Cov.: 23 AF XY: 0.000145 AC XY: 5AN XY: 34510
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2021 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | TAFAZZIN: BP4, BS2 - |
3-Methylglutaconic aciduria type 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at